Express News | Pfizer Exec Says Co Will Not Comment on Speculation Regarding the Sale of Its Hospital Drugs Unit
Express News | Pfizer (PFE) sues Sandoz, hoping to block the launch of generic drugs for its Inlyta (axitinib, a drug used to treat kidney cell cancer).
UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
UBS Remains a Hold on Pfizer (PFE)
Express News | Pfizer plans to sell the pharmaceutical department of the hospital, the company's response: no comment.
Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?